Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.
Salvia BioElectronics has raised $60.4M in total funding. The most recent round was Series B. The last funding was announced in May 2025.
Salvia BioElectronics's investors include Invest-NL, Innovation Industries, Panakes Partners, Inkef, SHS Capital.
Salvia BioElectronics is headquartered in Eindhoven, The Netherlands.
Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.
Salvia BioElectronics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Salvia BioElectronics — Funding & Investors." VCBacked, May 27, 2025, https://www.vcbacked.co/company/salvia-bioelectronics. Accessed October 29, 2026.
VCBacked. (2025). Salvia BioElectronics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/salvia-bioelectronics
{{cite web |title=Salvia BioElectronics — Funding & Investors |url=https://www.vcbacked.co/company/salvia-bioelectronics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated